| Date | Time | Source | Headline | Symbol | Company |
| 02/14/2014 | 2:15PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 10/10/2013 | 2:54PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/23/2013 | 8:35AM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/17/2013 | 5:00AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/17/2013 | 5:00AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 5:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 5:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 5:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 5:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 5:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 5:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 3:03PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 3:03PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 3:02PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 3:02PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 3:02PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 3:02PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 3:02PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/13/2013 | 3:01PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/11/2013 | 4:11PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/11/2013 | 4:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/11/2013 | 4:08PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/11/2013 | 3:30PM | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/11/2013 | 3:30PM | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/11/2013 | 3:26PM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/11/2013 | 10:00AM | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/11/2013 | 10:00AM | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/06/2013 | 3:01PM | GlobeNewswire Inc. | Trius Therapeutics to Present Data From Antibiotics Development Programs at ICAAC 2013 | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/05/2013 | 3:51PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 09/05/2013 | 3:46PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |